Financhill
Back

Kymera Therapeutics Quote, Financials, Valuation and Earnings

Kymera Therapeutics Price Quote

$40.66
+0.02 (+3.88%)
(Updated: December 21, 2024 at 5:34 AM ET)

Kymera Therapeutics Key Stats

Sell
39
Kymera Therapeutics (KYMR) is a Sell

Day range:
$38.24 - $40.78
52-week range:
$22.35 - $53.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
32.31
P/B ratio:
2.95%

Volume:
1.1M
Avg. volume:
495.1K
1-year change:
65.88%
Market cap:
$2.6B
Revenue:
$78.6M
EPS:
$-2.34

How Much Does Kymera Therapeutics Make?

Data Unavailable

Is Kymera Therapeutics Growing As A Company?

Data Unavailable

Kymera Therapeutics Stock Price Performance

What Is Kymera Therapeutics 52-Week High & Low?

Kymera Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Kymera Therapeutics?

Data Unavailable

Is Kymera Therapeutics Cash Flow Positive?

Data Unavailable

Kymera Therapeutics Return On Invested Capital

Data Unavailable

Kymera Therapeutics Earnings Date & Stock Price

Kymera Therapeutics Competitors

Kymera Therapeutics Dividend Yield

Data Unavailable

Kymera Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 2.93%
Revenue: -20.88% -63.81%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 58.74
Upside from Last Price: 44.53%

Major Shareholders

Data Unavailable